dosing for ghk cu peptide GHK-Cu Dosage and Protocol: The 30-Day Cycle GHK-CU Peptide Dosage: Complete Guide

Usually mild and diminishing with continued use

When a peptide is injected subcutaneously, it bypasses the digestive system entirely

The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons

Not for medical, veterinary, diagnostic, or therapeutic use